Detailed program coming soon, check back for more details.

Plenary Sessions

Plenary Session 1: MSCs – Results from the clinic and the paths forward

Chair:

 

 

 


Allan Dietz, PhD
, Mayo Clinic, United States

Plenary Session 2: Emerging Engineering Strategies in Regenerative Medicine

Chair:

 

 

 

 

William Murphy, PhDUniversity of Madison-Wisconsin, United States

Plenary Session 3: Redirecting Immune Cells – T and NK cells aside from canonical CARs

Chair:

Sarah Nikiforow, MD, PhD, Dana-Farber Cancer Center, United States

Plenary Session 4: iPS Pluripotent Stem Cells - True Replacement Cell Therapies

Chair:

 

 

 

 

Robert Deans, PhD, BlueRock Therapeutics, United States

 

Workshop Sessions

Workshop Session 1: NAVRMA Joint Session - Veterinary medicine in developing cell based therapies and bioengineering approach for human clinical use

Co-Chairs:

Daniel Weiss, MD, PhD, University of Vermont, United States

Workshop Session 2: ISCT PTF Session – Regulatory aspects of Unproven Cell Therapies in North America

Chair:

 

 

 

 

Laertis Ikonomou, PhD, Boston University, United States

Workshop Session 3: Optimizing Clinical Trials in Cellular Therapy

Chair:

 

 

 

 

Denis-Claude Roy, MD, University of Montreal / CellCAN, Canada

Workshop Session 4: Engineering to Control Cell Environment during Expansion

Chair:

 

 

 

 

Erika Trauzzi, PhD, MBA, Berkeley Lights, United States

Workshop Session 5: Gene Replacement Therapy Using Adult Stem Cells

Chair:

 

 

 

 

Mitchell Cairo, MD, New York Medical College, United States

Workshop Session 6: CAR-T Racing: Amateurs & Rookies Looking to Contribute

Chair:

 

 

 

 

Patrick Hanley, PhD, Children's National Health System, United States

Workshop Session 7: FDA & Other Government Agencies

Chair:

 

 

 

 

Lizette Caballero, BS, MT(ASCP), UCSF Blood and Marrow Transplant Lab, United States

Workshop Session 8: CAR-T Racing: The Pro Circuit + Future

Chair:

 

 

 

 

Bruce Levine, PhD, Barbara and Edward Netter Professor in Cancer Gene Therapy,
University of Pennsylvania, United States

 

Quality & Operations Track

Session details available soon